IFM Therapeutics
400 Technology Square, 10th Floor
Cambridge
Massachusetts
02139
U.S.A.
Phone:
n/a
Fax:
n/a
|
IFM Therapeutics is a privately held biopharmaceutical company based in Cambridge, Massachusetts. Seeded by Atlas Venture, the company was founded in 2015 by an international group of preeminent scientists and physicians to discover and develop small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity, and inflammatory disorders. Drugs in the IFM portfolio are expected to significantly improve upon standard of care agents in terms of efficacy and safety. For more information, please visit www.ifmthera.com.
YEAR FOUNDED:
October 2011
LEADERSHIP:
CEO: Gary D. Glick
Chief Development Officer: Dennis Dean
Chief Scientific Officer: Shomir Ghosh
Email:
info@ifmthera.com
Ownership:
Private
Web Site:
IFM Therapeutics
Employees:
Symbol:
|